Literature DB >> 1284534

Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium.

L C Tsui1.   

Abstract

Cystic fibrosis is the most common autosomal disorder in the Caucasian population. Since the description of the major mutation of this disease in 1989, over 150 of additional mutations have been identified in the CFTR gene. This update summarizes the different mutations identified and reported before March 15 by members of the international Cystic Fibrosis Genetic Analysis Consortium. The report includes information on DNA sequence variations found in the gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284534     DOI: 10.1002/humu.1380010304

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  47 in total

1.  Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.

Authors:  M Srivastava; O Eidelman; H B Pollard
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

2.  Functional rescue of a misfolded eukaryotic ATP-binding cassette transporter by domain replacement.

Authors:  Raymond J Louie; Silvere Pagant; Ji-Young Youn; John J Halliday; Gregory Huyer; Susan Michaelis; Elizabeth A Miller
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

3.  Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum.

Authors:  Iris Schrijver; Sudha Ramalingam; Ramalingam Sankaran; Steve Swanson; Charles L M Dunlop; Steven Keiles; Richard B Moss; John Oehlert; Phyllis Gardner; E Robert Wassman; Anja Kammesheidt
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

4.  Common genetic variants account for differences in gene expression among ethnic groups.

Authors:  Richard S Spielman; Laurel A Bastone; Joshua T Burdick; Michael Morley; Warren J Ewens; Vivian G Cheung
Journal:  Nat Genet       Date:  2007-01-07       Impact factor: 38.330

5.  A novel computational and structural analysis of nsSNPs in CFTR gene.

Authors:  C George Priya Doss; R Rajasekaran; C Sudandiradoss; K Ramanathan; R Purohit; R Sethumadhavan
Journal:  Genomic Med       Date:  2008-05-14

Review 6.  Recent advances in cystic fibrosis.

Authors:  G Santis; D Geddes
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

7.  Two new mutations detected by single-strand conformation polymorphism analysis in cystic fibrosis from Russia.

Authors:  T E Ivaschenko; V S Baranov; M Dean
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

8.  SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation.

Authors:  Shyam Ramachandran; Samantha R Osterhaus; Kalpaj R Parekh; Ashley M Jacobi; Mark A Behlke; Paul B McCray
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

9.  CF2603/4delT, a new frameshift mutation in exon 13 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  B Ezquieta; J Molano
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

10.  Chemical rescue of deltaF508-CFTR mimics genetic repair in cystic fibrosis bronchial epithelial cells.

Authors:  Om V Singh; Harvey B Pollard; Pamela L Zeitlin
Journal:  Mol Cell Proteomics       Date:  2008-02-19       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.